Stocksigma LogoStocksigma Logo

Omkar Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 9.0 (-33.3% YoY | +0.0% QoQ) ■ EBITDA: 0.4 (-93.7% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 4.7 (-4459 bps YoY | Loss to Profit QoQ) ■

Omkar Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Omkar Pharmachem Ltd · Outcome · 14 Nov 2026, 10:52 pm

Omkar Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 9.0 (-33.3% YoY | +0.0% QoQ) ■ EBITDA: 0.4 (-93.7% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 4.7 (-4459 bps YoY | Loss to Profit QoQ) ■ PAT: 0.4 (-92.3% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.00 (-92.2% YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Omkar Pharmachem Ltd

All Omkar Pharmachem Ltd announcements